Megasoft Limited (NSE:MEGASOFT)
India · Delayed Price · Currency is INR 114.48
-6.03 (-5.00%)
Aug 13, 2025, 3:29 PM IST
bluebird bio Revenue
Megasoft had revenue of 1.85B INR in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 1.78B.
Revenue (ttm)
1.78B
Revenue Growth
n/a
P/S Ratio
4.96
Revenue / Employee
2.01M
Employees
885
Market Cap
8.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 19.71M | -504.25M | -96.24% |
| Mar 31, 2022 | 523.96M | -70.06M | -11.79% |
| Mar 31, 2021 | 594.02M | 26.70M | 4.71% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 232.42B |
| Fortis Healthcare | 80.94B |
| Aurobindo Pharma | 320.25B |